Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries

B. Schweikert, D. Pittrow, D. Vizza, J. Pepke-Zaba, M. Hoeper, A. Gabriel, J. Berg, M. Sikirica (Munich, Dresden, Hanover, Wuppertal, Berlin, Germany; Rome, Italy; Cambridge, United Kingdom; Stockholm, Sweden)

Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Session: Pulmonary circulation: acute and chronic pulmonary embolism
Session type: Thematic Poster Session
Number: 3893
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Schweikert, D. Pittrow, D. Vizza, J. Pepke-Zaba, M. Hoeper, A. Gabriel, J. Berg, M. Sikirica (Munich, Dresden, Hanover, Wuppertal, Berlin, Germany; Rome, Italy; Cambridge, United Kingdom; Stockholm, Sweden). Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries. Eur Respir J 2012; 40: Suppl. 56, 3893

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Treatment patterns of COPD patients in France: A retrospective analysis of an administrative primary care healthcare database
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Evaluation of the demographics, diagnosis and monitoring, management, device usage and adherence among COPD patients: A survey of doctors in Nepal
Source: International Congress 2018 – COPD around the world
Year: 2018

Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021

Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data.
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021



Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study
Source: Eur Respir J, 54 (4) 1900444; 10.1183/13993003.00444-2019
Year: 2019



Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018

A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data
Source: Annual Congress 2008 - Management of COPD
Year: 2008



The cost burden of COPD in France: A retrospective analysis of an administrative primary care database
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017


The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Asthma management and utilization of healthcare services in children: the results of a population-based survey
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
Source: Eur Respir J, 50 (3) 1700644; 10.1183/13993003.00644-2017
Year: 2017



Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017


DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


Socio-demographic and clinical characteristics of patients with tuberculosis and diabetes in European countries. A TB-net study
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008


The economic burden of COPD in a Swedish cohort: The ARCTIC study
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016